ID   ACKR4_HUMAN             Reviewed;         350 AA.
AC   Q9NPB9; B2R9U7;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   07-APR-2021, entry version 168.
DE   RecName: Full=Atypical chemokine receptor 4;
DE   AltName: Full=C-C chemokine receptor type 11;
DE            Short=C-C CKR-11;
DE            Short=CC-CKR-11;
DE            Short=CCR-11;
DE   AltName: Full=CC chemokine receptor-like 1;
DE            Short=CCRL1;
DE   AltName: Full=CCX CKR;
GN   Name=ACKR4; Synonyms=CCBP2, CCR11, CCRL1, VSHK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=10767544; DOI=10.1016/s0378-1119(00)00076-7;
RA   Khoja H., Wang G., Ng C.-T.L., Tucker J., Brown T., Shyamala V.;
RT   "Cloning of CCRL1, an orphan seven transmembrane receptor related to
RT   chemokine receptors, expressed abundantly in the heart.";
RL   Gene 246:229-238(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=10734104; DOI=10.1074/jbc.275.13.9550;
RA   Schweickart V.L., Epp A., Raport C.J., Gray P.W.;
RT   "CCR11 is a functional receptor for the monocyte chemoattractant protein
RT   family of chemokines.";
RL   J. Biol. Chem. 275:9550-9556(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION IN CHEMOKINES BINDING.
RX   PubMed=10706668; DOI=10.4049/jimmunol.164.6.2851;
RA   Gosling J., Dairaghi D.J., Wang Y., Hanley M., Talbot D., Miao Z.,
RA   Schall T.J.;
RT   "Identification of a novel chemokine receptor that binds dendritic
RT   cell- and T cell-active chemokines including ELC, SLC, and TECK.";
RL   J. Immunol. 164:2851-2856(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=11981810;
RX   DOI=10.1002/1521-4141(200205)32:5<1230::aid-immu1230>3.0.co;2-l;
RA   Townson J.R., Nibbs R.J.;
RT   "Characterization of mouse CCX-CKR, a receptor for the lymphocyte-
RT   attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3beta/mCCL19:
RT   comparison to human CCX-CKR.";
RL   Eur. J. Immunol. 32:1230-1241(2002).
RN   [8]
RP   REVIEW.
RX   PubMed=20373092; DOI=10.1007/82_2010_19;
RA   Bonecchi R., Savino B., Borroni E.M., Mantovani A., Locati M.;
RT   "Chemokine decoy receptors: structure-function and biological properties.";
RL   Curr. Top. Microbiol. Immunol. 341:15-36(2010).
RN   [9]
RP   REVIEW.
RX   PubMed=22698181; DOI=10.1016/j.imlet.2012.04.004;
RA   Graham G.J., Locati M., Mantovani A., Rot A., Thelen M.;
RT   "The biochemistry and biology of the atypical chemokine receptors.";
RL   Immunol. Lett. 145:30-38(2012).
RN   [10]
RP   REVIEW.
RX   PubMed=23356288; DOI=10.1042/bst20120246;
RA   Cancellieri C., Vacchini A., Locati M., Bonecchi R., Borroni E.M.;
RT   "Atypical chemokine receptors: from silence to sound.";
RL   Biochem. Soc. Trans. 41:231-236(2013).
RN   [11]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=23121557; DOI=10.1111/bph.12042;
RA   Vinet J., van Zwam M., Dijkstra I.M., Brouwer N., van Weering H.R.,
RA   Watts A., Meijer M., Fokkens M.R., Kannan V., Verzijl D., Vischer H.F.,
RA   Smit M.J., Leurs R., Biber K., Boddeke H.W.;
RT   "Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-
RT   like protein CCX-CKR.";
RL   Br. J. Pharmacol. 168:1375-1387(2013).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH ARRB1 AND ARRB2.
RX   PubMed=23341447; DOI=10.1074/jbc.m112.406108;
RA   Watts A.O., Verkaar F., van der Lee M.M., Timmerman C.A., Kuijer M.,
RA   van Offenbeek J., van Lith L.H., Smit M.J., Leurs R., Zaman G.J.,
RA   Vischer H.F.;
RT   "Beta-arrestin recruitment and G protein signaling by the atypical human
RT   chemokine decoy receptor CCX-CKR.";
RL   J. Biol. Chem. 288:7169-7181(2013).
CC   -!- FUNCTION: Atypical chemokine receptor that controls chemokine levels
CC       and localization via high-affinity chemokine binding that is uncoupled
CC       from classic ligand-driven signal transduction cascades, resulting
CC       instead in chemokine sequestration, degradation, or transcytosis. Also
CC       known as interceptor (internalizing receptor) or chemokine-scavenging
CC       receptor or chemokine decoy receptor. Acts as a receptor for chemokines
CC       CCL2, CCL8, CCL13, CCL19, CCL21 and CCL25. Chemokine-binding does not
CC       activate G-protein-mediated signal transduction but instead induces
CC       beta-arrestin recruitment, leading to ligand internalization. Plays an
CC       important role in controlling the migration of immune and cancer cells
CC       that express chemokine receptors CCR7 and CCR9, by reducing the
CC       availability of CCL19, CCL21, and CCL25 through internalization.
CC       Negatively regulates CXCR3-induced chemotaxis. Regulates T-cell
CC       development in the thymus. {ECO:0000269|PubMed:10706668,
CC       ECO:0000269|PubMed:23121557, ECO:0000269|PubMed:23341447}.
CC   -!- SUBUNIT: Forms heteromers with CXCR3. Interacts with ARRB1 and ARRB2.
CC       {ECO:0000269|PubMed:23121557, ECO:0000269|PubMed:23341447}.
CC   -!- SUBCELLULAR LOCATION: Early endosome {ECO:0000269|PubMed:23341447}.
CC       Recycling endosome {ECO:0000269|PubMed:23341447}. Cell membrane
CC       {ECO:0000269|PubMed:23341447}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:23341447}. Note=Predominantly localizes to
CC       endocytic vesicles, and upon stimulation by the ligand is internalized
CC       via caveolae. Once internalized, the ligand dissociates from the
CC       receptor, and is targeted to degradation while the receptor is recycled
CC       back to the cell membrane.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in heart. Lower expression
CC       in lung, pancreas, spleen, colon, skeletal muscle and small intestine.
CC       {ECO:0000269|PubMed:10734104, ECO:0000269|PubMed:10767544,
CC       ECO:0000269|PubMed:11981810}.
CC   -!- PTM: The Ser/Thr residues in the C-terminal cytoplasmic tail may be
CC       phosphorylated.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Atypical chemokine receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF110640; AAF59827.1; -; mRNA.
DR   EMBL; AF193507; AAF61299.1; -; Genomic_DNA.
DR   EMBL; AF233281; AAF44751.1; -; Genomic_DNA.
DR   EMBL; AY221094; AAO65972.1; -; Genomic_DNA.
DR   EMBL; AK313923; BAG36644.1; -; mRNA.
DR   EMBL; BC069438; AAH69438.1; -; mRNA.
DR   CCDS; CCDS3075.1; -.
DR   RefSeq; NP_057641.1; NM_016557.3.
DR   RefSeq; NP_848540.1; NM_178445.2.
DR   BioGRID; 119606; 5.
DR   DIP; DIP-5918N; -.
DR   IntAct; Q9NPB9; 2.
DR   STRING; 9606.ENSP00000249887; -.
DR   GuidetoPHARMACOLOGY; 315; -.
DR   GlyGen; Q9NPB9; 2 sites.
DR   iPTMnet; Q9NPB9; -.
DR   PhosphoSitePlus; Q9NPB9; -.
DR   BioMuta; ACKR4; -.
DR   DMDM; 14285406; -.
DR   MassIVE; Q9NPB9; -.
DR   PaxDb; Q9NPB9; -.
DR   PRIDE; Q9NPB9; -.
DR   ProteomicsDB; 81962; -.
DR   Antibodypedia; 17718; 245 antibodies.
DR   Ensembl; ENST00000249887; ENSP00000249887; ENSG00000129048.
DR   GeneID; 51554; -.
DR   KEGG; hsa:51554; -.
DR   UCSC; uc003eow.5; human.
DR   CTD; 51554; -.
DR   DisGeNET; 51554; -.
DR   GeneCards; ACKR4; -.
DR   HGNC; HGNC:1611; ACKR4.
DR   HPA; ENSG00000129048; Tissue enhanced (intestine, salivary gland).
DR   MIM; 606065; gene.
DR   neXtProt; NX_Q9NPB9; -.
DR   OpenTargets; ENSG00000129048; -.
DR   PharmGKB; PA35036; -.
DR   VEuPathDB; HostDB:ENSG00000129048.6; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01020000230481; -.
DR   HOGENOM; CLU_009579_8_3_1; -.
DR   InParanoid; Q9NPB9; -.
DR   OMA; MCKVTSA; -.
DR   OrthoDB; 839817at2759; -.
DR   PhylomeDB; Q9NPB9; -.
DR   TreeFam; TF330966; -.
DR   PathwayCommons; Q9NPB9; -.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   BioGRID-ORCS; 51554; 10 hits in 952 CRISPR screens.
DR   ChiTaRS; ACKR4; human.
DR   GeneWiki; CCRL1; -.
DR   GenomeRNAi; 51554; -.
DR   Pharos; Q9NPB9; Tbio.
DR   PRO; PR:Q9NPB9; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9NPB9; protein.
DR   Bgee; ENSG00000129048; Expressed in thoracic aorta and 110 other tissues.
DR   ExpressionAtlas; Q9NPB9; baseline and differential.
DR   Genevisible; Q9NPB9; HS.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0019957; F:C-C chemokine binding; IBA:GO_Central.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IBA:GO_Central.
DR   GO; GO:0004950; F:chemokine receptor activity; IDA:UniProtKB.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0019722; P:calcium-mediated signaling; IBA:GO_Central.
DR   GO; GO:0060326; P:cell chemotaxis; IBA:GO_Central.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   InterPro; IPR005383; ACKR4.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR01558; CHEMOKINER11.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Endosome; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Phosphoprotein; Receptor; Reference proteome;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..350
FT                   /note="Atypical chemokine receptor 4"
FT                   /id="PRO_0000069296"
FT   TOPO_DOM        1..42
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        43..63
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        64..87
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        88..108
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        109..113
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        114..134
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        135..154
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        155..175
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        176..201
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        202..222
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        223..240
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        241..261
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        262..289
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        290..310
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        311..350
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        6
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        19
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        112..184
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   350 AA;  39914 MW;  8E26049D2D5757C8 CRC64;
     MALEQNQSTD YYYEENEMNG TYDYSQYELI CIKEDVREFA KVFLPVFLTI VFVIGLAGNS
     MVVAIYAYYK KQRTKTDVYI LNLAVADLLL LFTLPFWAVN AVHGWVLGKI MCKITSALYT
     LNFVSGMQFL ACISIDRYVA VTKVPSQSGV GKPCWIICFC VWMAAILLSI PQLVFYTVND
     NARCIPIFPR YLGTSMKALI QMLEICIGFV VPFLIMGVCY FITARTLMKM PNIKISRPLK
     VLLTVVIVFI VTQLPYNIVK FCRAIDIIYS LITSCNMSKR MDIAIQVTES IALFHSCLNP
     ILYVFMGASF KNYVMKVAKK YGSWRRQRQS VEEFPFDSEG PTEPTSTFSI
//
